Hippocratic AI · 1 day ago
Regulatory Evaluator, HCP Sales (AI)
Hippocratic AI is a leading healthcare AI company focused on developing safe, safety-focused Large Language Models for healthcare. The Regulatory Evaluator will review and assess AI-enabled Voice AI interactions for regulatory compliance, ensuring adherence to applicable regulatory frameworks and managing regulatory risks.
Artificial Intelligence (AI)Generative AIHealth CareInformation Technology
Responsibilities
Review and evaluate HCP- and patient-facing Voice AI interactions for regulatory compliance
Assess alignment with approved labeling, regulatory guidance, and promotional boundaries
Identify regulatory risk, ambiguity, or precedent concerns in AI-driven interactions
Apply real-world regulatory judgment to distinguish material risk from low-risk deviations
Score interactions using defined regulatory rubrics and provide clear, actionable feedback
Flag potential regulatory compliance risks and areas requiring escalation or mitigation
Qualification
Required
3–10+ years of experience in Pharmaceutical Regulatory Affairs
Direct involvement in MLR/PRC review processes as a Regulatory contributor or decision-maker
Strong understanding of promotional regulations, labeling, and regulatory risk assessment
Ability to make clear, defensible regulatory judgment calls
Strong written communication skills
Fluency in English
Reliable access to a computer and high-speed internet
Preferred
Experience reviewing digital, omnichannel, or AI-enabled promotional content
Familiarity with Voice AI, chat-based agents, or automated engagement tools
Experience in fast-moving, ambiguous regulatory environments
Exposure to startup, digital health, or innovation-focused teams
Company
Hippocratic AI
Hippocratic AI is a healthcare technology company that develops safety-focused large-language models for medical applications.
Funding
Current Stage
Growth StageTotal Funding
$402MKey Investors
AvenirKleiner PerkinsNVentures
2025-11-03Series C· $126M
2025-01-09Series B· $141M
2024-09-19Series A· $17M
Recent News
generalcatalyst.com
2026-01-05
generalcatalyst.com
2026-01-05
Company data provided by crunchbase